Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Johnson and Johnson Gets CDSCO Panel Nod for Talqetamab in Relapsed Multiple Myeloma, Phase IV Trial Mandated

JnJ Nipocalimab gets USFDA Fast Track designation for Sjogren's disease

Ruchika Sharma19 March 2025 1:30 PM IST

Spring House: Johnson & Johnson has received Fast Track designation (FTD) from the U.S. Food and Drug Administration (FDA) for...

LIC eyes entry into health insurance space by month end

Ruchika Sharma19 March 2025 12:30 PM IST

The Life Insurance Corporation of India (LIC) is expected to make a decision to buy a stake in a health insurance company by the March end, according...

Zydus Lifesciences bags USFDA nod for prostate cancer drug Apalutamide

Ruchika Sharma19 March 2025 11:30 AM IST

Ahmedabad: Pharma major, Zydus Lifesciences Limited, has received final approval from the United States Food and Drug Administration (USFDA) to...

Strides Pharma Science arm voluntarily dissolves

Ruchika Sharma19 March 2025 10:30 AM IST

Bengaluru: Strides Pharma Science has announced that Generic Partners UK Ltd, a step-down wholly owned subsidiary of the Company, has been...

Religare Enterprises seeks funding from Burman family

Ruchika Sharma18 March 2025 5:13 PM IST

Board of Religare Enterprises is seeking a governance review of the company and its units. Additionally, the financial services provider has...

Novo Nordisk Bets on Oral Wegovy to Take on Eli Lilly in US Obesity Market

Novo Nordisk regains membership in UK pharma body

Ruchika Sharma18 March 2025 3:30 PM IST

London: Danish pharmaceutical giant Novo Nordisk has regained its membership in the UK's pharmaceutical industry body after serving a two-year...

Shilpa Biologicals, mAbTree Biologics ink pact for cancer drug

Ruchika Sharma18 March 2025 12:30 PM IST

Karnataka: Shilpa Biologicals Pvt Ltd., a fully owned subsidiary of Shilpa Medicare Limited has signed an exclusive partnership...

Alembic Pharma secures USFDA approval for Travoprost Ophthalmic Solution

Alembic Global Holding incorporates wholly-owned subsidiary in USA

Ruchika Sharma18 March 2025 11:30 AM IST

Vadodara: Alembic Global Holding SA, a wholly owned subsidiary of Alembic Pharmaceuticals Limited has incorporated a wholly-owned subsidiary in USA,...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

AstraZeneca, Alteogen ink pact for subcutaneous formulations of multiple oncology assets

Ruchika Sharma18 March 2025 10:30 AM IST

Cambridge: AstraZeneca and Alteogen Inc. have entered into an exclusive license agreement for ALT-B4, a novel hyaluronidase utilising Hybrozyme...

Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources

Strides Pharma Science Singapore arm to acquire 100 percent stake in Amexel

Ruchika Sharma17 March 2025 5:38 PM IST

Bangalore: Strides Pharma Global Pte. Limited (SPG), a step-down wholly-owned Subsidiary of Strides Pharma Science Limited in Singapore, has...

Dr Reddys Labs secures European Commission approval for biosimilar to treat osteoporosis

Dr Reddy's Labs recalls epilepsy drug in US over infusion bag mislabeling

Ruchika Sharma17 March 2025 5:28 PM IST

Hyderabad: Dr Reddy’s Laboratories Ltd., is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 ...

Bayer new drug application for gadoquatrane accepted for review in China

Bayer Finerenone secures USFDA Priority Review designation for heart failure

Ruchika Sharma17 March 2025 4:30 PM IST

Berlin: Bayer has announced that the Company has received Priority Review designation from the U.S. Food and Drug Administration (FDA) for finerenone...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok